Abstract:Depression is a common and complex psychiatric illness with multiple clinical symptoms, even leading to the disability and suicide. Owing to the partial understanding of the pathogenesis of depressive-like disorders, available pharmacotherapeutic strategies are developed mainly based on the "monoamine hypothesis", resulting in a limited effectiveness and a number of adverse effects in the clinical practice. The concept of multiple pathogenic factors be helpful for clarifying the etiology of depression and developing the antidepressants. It is well documented that K+ channels serve crucial roles in modulating the neuronal excitability and neurotransmitter release in the brain, and abnormality of these channels participated in the pathogenic process of diverse central nervous system (CNS) pathologies, such as seizure and Alzheimer's disease (AD). The clinical and preclinical evidence also delineates that the involvement of several types of K+ channels in depressive-like behaviors appear to be evident, suggesting these channels being one of the multiple factors in the etiology of this debilitating disorder. Emerging data manifest that diverse antidepressants impact distinct K+ channels, such as Kv, Kir and K2P, meaning the functioning of these drug via a "multi-target" manner. On the other hand, the scenario of antidepressants impinging K+ channels could render an alternative interpretation for the pharmacological effectiveness and numerous side effects in clinical trials. Furthermore, these channels serve to be considered as a "druggable target" to develop novel therapeutic compound to antagonize this psychiatry.

Research progress on the relationship between tachykinin/ tachykinin receptors and depression

Research Progress on Neural Circuit Mechanisms of Depression

Progress of Receptors, Cytokine and Signal Pathways about Depression

The Link Between Long Noncoding RNAs and Depression.

Research Progress of BDNF and Depression

The association of oxytocin with major depressive disorder: role of confounding effects of antidepressants

Research progress in inflammation and reward mechanisms and traditional Chinese medicine regulation of depression

[Research progress on the mechanism of acupuncture on depression based on signaling pathway regulation]

Exploring the Association between BDNF related Signaling Pathways and Depression: A Literature Review

Research progress of neuroendocrine immune inflammation in depression

A Review of Research on the Association between Neuron-Astrocyte Signaling Processes and Depressive Symptoms

Research Progress on Natural Compounds Exerting an Antidepressant Effect through Anti-inflammatory

The role and mechanism of tryptophan – kynurenine metabolic pathway in depression

Research progress of acupuncture regulating ERK signaling pathway in the treatment of depression

The involvement of K+ channels in depression and pharmacological effects of antidepressants on these channels

Neurotrophic basis to the pathogenesis of depression and phytotherapy

Research status of neuro-immunological targets in pathogenesis of depression

Reseach progress in neuroinflammation mechanism in depression.

The receptor hypothesis and the pathogenesis of depression: Genetic bases and biological correlates

Pathogenesis of depression and the mechanism research in TCM treatment of major depression

The therapeutic potential of traditional Chinese medicine in depression: focused on the modulation of neuroplasticity